Heerlen, NL, 02 Nov 2010 07:15 CET
Commenting on the results, Feike Sijbesma, Chairman of the DSM Managing Board, said: “I am pleased to report another strong quarter. Operating profit increased by almost 30% compared to the same period last year. Nutrition delivered a continued excellent performance, whilst Materials Sciences also posted very good results. Our strong market focus, disciplined cost and cash management and a broadly improving business environment helped drive these results. Based on the continued positive business environment we expect 2010 to be a strong year for DSM.
“The announcement of our new corporate strategy – DSM in motion: driving focused growth – marks the shift from a period of intensive portfolio management to an era of maximizing sustainable, profitable growth of the ‘new’ DSM. We are committed to fully leverage the unique opportunities in Life Sciences and Materials Sciences. With our focus on high growth economies, innovation and sustainability and with our strong capital structure and leadership in biotechnology we are in an excellent position to deliver on our ambitious sales and profit targets.”
|Q3 2010||Q3 2009||+/-||in € million||Jan - Sep 2010||Jan - Sep 2011||+/-|
|288||249||16%||Operating profit before depreciation & amortization (EBITDA)||937||567||65%|
|185||144||28%||Operating profit (EBIT)||622||268||132%|
|19||7||Base Chemicals and Materials||54||-23|
|4||34||Operating profit before depreciation & amortization (EBITDA)||51||75|
|3||21||Operating profit (EBIT)||36||33|
|188||165||14%||Operating profit (EBIT)||658||301||119%|
|128||100||Net profit before exceptional items||430||155|
|-49||274||Net result from exceptional items||-72||242|
|Net earnings per ordinary share in €:|
|0.76||0.53||before exceptional items, continuing operations||2.44||0.80|
|0.46||2.29||including exceptional items, total DSM||2.14||2.40|
You can find the press release in full, including financial statements, below.